Multi-platform coverage! Xiamen Winbio Bio’s raw materials are compatible with luminescence, ELISA, fluorescence, and colloidal gold assays.


Xiamen Winbio Biotechnology Co., Ltd., leveraging a mature R&D platform, offers antigen, antibody, and recombinant protein active raw materials—along with tailored solutions—compatible with multiple technological platforms for in vitro diagnostic customers. Founded in 2017 and located in the Haicang Biomedical Industrial Park, the company is a national-level high-tech enterprise and a specialized, refined, distinctive, and innovative enterprise recognized by Xiamen City. Winbio Biotechnology boasts a comprehensive product portfolio, supporting the development of mainstream IVD platforms, including chemiluminescence, ELISA, fluorescence immunoassay, and colloidal gold rapid tests. Different assay platforms have distinct requirements for raw material labeling performance, specificity, and stability. The company’s core team comprises seasoned experts with over 30 years of experience and key technical leaders from across the industry chain, enabling targeted optimization of raw materials to suit specific platform characteristics and providing accompanying application‑process guidance. From recombinant protein expression and antigen–antibody preparation to raw material performance validation and platform‑specific tuning, Winbio Biotechnology has established end-to-end service capabilities, offering one-stop support for reagent manufacturers’ multi‑pipeline development and delivering reliable raw material supplies for the creation of diverse in vitro diagnostic products.

Xiamen Winbio Biotechnology Co., Ltd., leveraging a mature R&D platform, offers antigen, antibody, and recombinant protein active raw materials—compatible with multiple technological platforms—along with tailored solutions for in vitro diagnostic customers. Founded in 2017 and located in the Haicang Biomedical Industrial Park, the company is a national-level high-tech enterprise and a specialized, refined, distinctive, and innovative enterprise recognized by Xiamen City.

Winbio Bio boasts a comprehensive product portfolio, capable of supporting the development of mainstream IVD platforms, including chemiluminescence, ELISA, fluorescence immunoassay, and colloidal gold rapid tests. Each assay platform has distinct requirements for reagent‑labeling performance, specificity, and stability. Our core team comprises seasoned experts with over 30 years of experience and key technical leaders across the industry chain, enabling us to tailor reagent optimization to the specific characteristics of each platform and provide corresponding application‑specific process‑guidance solutions.

From recombinant protein expression and antigen–antibody preparation to raw material performance validation and platform adaptation and optimization, Winbio Biotechnology has established end-to-end service capabilities, offering a one-stop solution to meet the multi‑pipeline development needs of reagent manufacturers and providing reliable raw material support for the development of diverse in‑vitro diagnostic products.

Leave a Message Online


Please provide the correct information, and we will contact you promptly!